Egyptian International Pharmaceutical Industries Company reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EGP 5,231.67 million compared to EGP 3,955.16 million a year ago. Net income was EGP 822.32 million compared to EGP 642.98 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
35.05 EGP | +1.62% | -2.56% | -3.97% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.97% | 110M | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- PHAR Stock
- News Egyptian International Pharmaceutical Industries Company
- Egyptian International Pharmaceutical Industries Company Reports Earnings Results for the Full Year Ended December 31, 2023